Kenyadah Gamble
Kenyadah Gamble is a government contact. Kenyadah is associated with 5 contracts. Activity spans In-Vitro Diagnostic Substance Manufacturing, Offices of Physicians (except Mental Health Specialists), and Medical Laboratories.
Person Profile
Contracting officer information and contact details
Kenyadah Gamble
Phone
+1 (555) 000-0000Last seen
Aug 26, 2026
Most recent solicitation activity
Role Type
PrimaryContracting Officer Overview
Industry focus, set-aside activity, and contract history for this federal contracting professional.
AI Professional Profile
Kenyadah M. Gamble serves as the primary contracting professional for the Defense Health Agency HCD West, overseeing the acquisition of mission-critical medical equipment and clinical support systems essential to sustaining operational readiness across the Indo-Pacific region. Responsible for managi...
Kenyadah M. Gamble serves as the primary contracting professional for the Defense Health Agency HCD West, overseeing the acquisition of mission-critical medical equipment and clinical support systems essential to sustaining operational readiness across the Indo-Pacific region. Responsible for managing the full lifecycle of procurements, Gamble specializes in securing advanced laboratory diagnostics, surgical instrumentation, and electromedical devices that directly support military medical personnel. Their work ensures timely delivery of high-reliability healthcare infrastructure, aligning procurement strategy with the agency’s mandate to maintain uninterrupted clinical capabilities in austere and deployed environments. Gamble maintains consistent partnerships with a select group of key contractors, including HEALTHSTREAM INC for training and compliance solutions, SENECA FEDERAL SOLUTIONS, LLC for logistics and technical support, AMD INTERNATIONAL TECHNOLOGIES LLC for specialized medical hardware, NOVARTIS PHARMACEUTICALS CORPORATION for diagnostic pharmaceuticals, and A.S.Y CO., LTD. for precision medical components. These relationships reflect a preference for established vendors with proven track records in defense-grade medical supply chains, emphasizing reliability, regulatory compliance, and rapid deployment capabilities. Gamble’s procurement portfolio is entirely non-set-aside, with 100% of awards issued under full and open competition. This reflects a strategic emphasis on technical capability and mission urgency over socioeconomic preferences, prioritizing performance and readiness over certification-based set-asides. While small business participation is not formally incentivized, vendor selection remains governed by stringent evaluation criteria focused on quality, compliance, and system interoperability. The primary procurement focus lies in NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing), 621111 (Offices of Physicians), and 621511 (Medical Laboratories), underscoring deep expertise in diagnostic testing systems, clinical workflow integration, and laboratory automation. Gamble’s domain knowledge centers on FDA-cleared and military-spec medical devices, reagent supply chains, and point-of-care diagnostic platforms critical to force health protection and battlefield triage.
Key Metrics
Total Contracts
5
Associated contracts
Industries
3
NAICS categories
Set-Aside Programs
1
Program types
Set-Aside Share
20%
Small-business awards
Procurement Analytics
Where this contracting officer directs award activity, by industry and small-business set-aside program.
Spending Trends
Spending Trends
Coming Soon
Works with
3 contracting officers
Recent Solicitations
Opportunities Kenyadah Gamble is the point of contact for
Reach the people behind federal awards
Know who buys, what they buy, and when they buy it again
Contract history and award activity for Kenyadah Gamble
Contact details and the offices each officer buys for
AI-powered matching between their requirements and your capabilities
Automated alerts when they post a new opportunity
Join 750+ contractors already using CLEATUS

